FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2047343684> ?p ?o ?g. }

• W2047343684 endingPage "467" @default.
• W2047343684 startingPage "457" @default.
• W2047343684 abstract "Prophylactic surgical removal of the ovaries has been offered for many years as a potential preventative of ovarian cancer in women deemed to be at increased hereditary risk for this disease. Now, it is possible to test for specific mutations of the BRCA1 and BRCA2 genes that render members of hereditary breast ovarian cancer (HBOC) syndrome families susceptible to cancer. Widespread intra-abdominal carcinomatosis, which mimics metastatic ovarian serous carcinoma, has been reported following oophorectomy in individuals at increased hereditary risk. This study was undertaken to examine and report particularly the occurrence of intra-abdominal carcinomatosis, as well as other cancers, following prophylactic oophorectomy in patients who carry cancer susceptibility mutations of BRCA1 and BRCA2 and to assess the cumulative risks for this disease in order to assist in developing appropriate surgical interventions, based on currently available information, and to counsel patients who choose prophylactic surgery, concerning the potential prognosis, thereafter.The Creighton University Hereditary Cancer Institute registry was searched for members of HBOC syndrome families who had undergone prophylactic oophorectomy. The histories and results of DNA testing for the BRCA1 and BRCA2 mutations carried in their families were recorded, tabulated and examined, and the aggregate data are reported along with pertinent details of those individuals who developed neoplastic diseases after prophylactic oophorectomy. All available histologic and cytologic materials of patients who were diagnosed with intra-abdominal carcinomatosis were reviewed, and life-table calculations were performed to assess cumulative risks for this disease following prophylactic oophorectomy.From 72 HBOC syndrome families that carried either BRCA1 or BRCA2 cancer-associated mutations, 238 individuals who had undergone prophylactic oophorectomy were recorded in our registry between January 1985 and December 2002. During a mean follow-up of 9.3 years, cancers were diagnosed in 27 subjects, including 16 individuals with breast cancer and five patients with intra-abdominal carcinomatosis. Breast cancers were stage I in 10 of 12 proven carriers of cancer-associated mutations. All five cases of intra-abdominal carcinomatosis were serous carcinomas, and all occurred in BRCA1 mutation carriers. Histologic review of the prophylactically removed ovaries found borderline lesions in two cases, one with possible early stromal invasion. Two of the five patients who developed intra-abdominal carcinomatosis were among 78 patients in this series who were diagnosed and treated for breast cancer before prophylactic oophorectomy. A 3.5% cumulative risk for all mutation carriers and a 3.9% cumulative risk for BRCA1 mutation carriers were calculated through 20 years of follow-up after prophylactic oophorectomy.Intra-abdominal carcinomatosis in our series was diagnosed only in BRCA1 mutation carriers. The calculated cumulative risks of developing intra-abdominal carcinomatosis after prophylactic oophorectomy in members of HBOC syndrome families, specifically those who carry deleterious mutations, are well below the estimated risks of ovarian cancer published in the literature for similar patients. Breast cancers, which tended to be small and localized, were the most common malignancy in BRCA1 and BRCA2 mutation carriers after prophylactic oophorectomy." @default.
• W2047343684 created "2016-06-24" @default.
• W2047343684 creator A5010712504 @default.
• W2047343684 creator A5011740148 @default.
• W2047343684 creator A5029960276 @default.
• W2047343684 creator A5062212676 @default.
• W2047343684 creator A5062502700 @default.
• W2047343684 creator A5088516335 @default.
• W2047343684 date "2005-05-01" @default.
• W2047343684 modified "2023-09-27" @default.
• W2047343684 title "Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations" @default.
• W2047343684 cites W1490006599 @default.
• W2047343684 cites W1903756730 @default.
• W2047343684 cites W1905467809 @default.
• W2047343684 cites W1964112201 @default.
• W2047343684 cites W1968788534 @default.
• W2047343684 cites W1969438890 @default.
• W2047343684 cites W1969447467 @default.
• W2047343684 cites W1973690102 @default.
• W2047343684 cites W1974999237 @default.
• W2047343684 cites W1976897902 @default.
• W2047343684 cites W1979710678 @default.
• W2047343684 cites W1983247267 @default.
• W2047343684 cites W1988242443 @default.
• W2047343684 cites W1995682043 @default.
• W2047343684 cites W1998115785 @default.
• W2047343684 cites W2006756815 @default.
• W2047343684 cites W2008506570 @default.
• W2047343684 cites W2011154946 @default.
• W2047343684 cites W2011427676 @default.
• W2047343684 cites W2015231552 @default.
• W2047343684 cites W2016058669 @default.
• W2047343684 cites W2018741636 @default.
• W2047343684 cites W2024386612 @default.
• W2047343684 cites W2025455201 @default.
• W2047343684 cites W2028527038 @default.
• W2047343684 cites W2029980305 @default.
• W2047343684 cites W2038793520 @default.
• W2047343684 cites W2039211343 @default.
• W2047343684 cites W2040247092 @default.
• W2047343684 cites W2041634324 @default.
• W2047343684 cites W2045733577 @default.
• W2047343684 cites W2050252843 @default.
• W2047343684 cites W2052234547 @default.
• W2047343684 cites W2052238358 @default.
• W2047343684 cites W2052313990 @default.
• W2047343684 cites W2057340839 @default.
• W2047343684 cites W2058003216 @default.
• W2047343684 cites W2059000312 @default.
• W2047343684 cites W2060277013 @default.
• W2047343684 cites W2064246320 @default.
• W2047343684 cites W2066494572 @default.
• W2047343684 cites W2070877786 @default.
• W2047343684 cites W2079195034 @default.
• W2047343684 cites W2079613384 @default.
• W2047343684 cites W2086247715 @default.
• W2047343684 cites W2086655228 @default.
• W2047343684 cites W2086725870 @default.
• W2047343684 cites W2086903029 @default.
• W2047343684 cites W2087025655 @default.
• W2047343684 cites W2087145961 @default.
• W2047343684 cites W2087603694 @default.
• W2047343684 cites W2091679505 @default.
• W2047343684 cites W2101699473 @default.
• W2047343684 cites W2103970959 @default.
• W2047343684 cites W2108049175 @default.
• W2047343684 cites W2113098178 @default.
• W2047343684 cites W2117902443 @default.
• W2047343684 cites W2122602946 @default.
• W2047343684 cites W2129990146 @default.
• W2047343684 cites W2135532761 @default.
• W2047343684 cites W2135914193 @default.
• W2047343684 cites W2139882858 @default.
• W2047343684 cites W2147078287 @default.
• W2047343684 cites W2150111967 @default.
• W2047343684 cites W2153847755 @default.
• W2047343684 cites W2156728001 @default.
• W2047343684 cites W2313384848 @default.
• W2047343684 cites W2315462006 @default.
• W2047343684 cites W2316696396 @default.
• W2047343684 cites W2316769474 @default.
• W2047343684 cites W2322804680 @default.
• W2047343684 cites W2328105863 @default.
• W2047343684 cites W2332773546 @default.
• W2047343684 cites W4236871322 @default.
• W2047343684 cites W4247549905 @default.
• W2047343684 cites W4319706142 @default.
• W2047343684 cites W8308331 @default.
• W2047343684 doi "https://doi.org/10.1016/j.ygyno.2005.01.039" @default.
• W2047343684 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15863145" @default.
• W2047343684 hasPublicationYear "2005" @default.
• W2047343684 type Work @default.
• W2047343684 sameAs 2047343684 @default.
• W2047343684 citedByCount "91" @default.
• W2047343684 countsByYear W20473436842012 @default.
• W2047343684 countsByYear W20473436842013 @default.
• W2047343684 countsByYear W20473436842014 @default.
• W2047343684 countsByYear W20473436842015 @default.

• next